What Shoulder Innovations, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 7 |
| Sells | 14 | 17 |
| Total trades | 20 | 49 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 92,802 | 239,283 |
| Disposed | 229,743 | 256,749 |
| Net activity | −136,941 | −17,466 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sidow Kevin K. | Director | Oct 05 | Grant / award · A | +892 | $19.60 | +$17.5K | 25,948 |
| Tansey Casey M | Director | Oct 05 | Grant / award · A | +733 | $19.60 | +$14.4K | 53,445 |
| Hykes Andrew | Director | Oct 05 | Grant / award · A | +669 | $19.60 | +$13.1K | 7,438 |
| Buckman Paul | Director | Oct 05 | Grant / award · A | +1,275 | $19.60 | +$25K | 65,025 |
| Ball Robert Joseph | CEO & Executive Chairman | Sep 14 | Open-market sale · S | −10,175 | $18.45 | −$188K | 380,824 |
| Ball Robert Joseph | CEO & Executive Chairman | Sep 14 | Exercise / conversion · M | +89,233 | $2.10 | +$187K | 390,999 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 26 | Open-market sale · S | −1,196 | $22.60 | −$27K | 2,185,914 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 24 | Open-market sale · S | −681 | $22.62 | −$15.4K | 2,187,110 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 21 | Open-market sale · S | −20,516 | $22.61 | −$464K | 2,187,791 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 20 | Open-market sale · S | −3,900 | $22.60 | −$88.1K | 2,208,307 |
| Ahearn Matthew Fraser | Chief Operating Officer | Aug 18 | Disclosed 10b5-1 sale · S | −1,600 | $21.38 | −$34.2K | 244,176 |
| Ahearn Matthew Fraser | Chief Operating Officer | Aug 18 | Disclosed 10b5-1 sale · S | −12,586 | $20.94 | −$263K | 245,776 |
| Ahearn Matthew Fraser | Chief Operating Officer | Aug 17 | Disclosed 10b5-1 sale · S | −8,314 | $20.10 | −$167K | 258,362 |
| Ahearn Matthew Fraser | Chief Operating Officer | Aug 14 | Gift · G | −2,500 | — | — | 266,676 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 06 | Open-market sale · S | −2,095 | $22.60 | −$47.3K | 2,212,207 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 05 | Open-market sale · S | −7,338 | $22.64 | −$166K | 2,214,302 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 04 | Open-market sale · S | −99,812 | $22.77 | −$2.27M | 2,221,640 |
| Gilde Healthcare Holding B.v. | 10% owner | Aug 03 | Open-market sale · S | −10,751 | $22.71 | −$244K | 2,321,452 |
| Gilde Healthcare Holding B.v. | 10% owner | Jul 31 | Open-market sale · S | −20,034 | $22.73 | −$455K | 2,332,203 |
| Gilde Healthcare Holding B.v. | 10% owner | Jul 30 | Open-market sale · S | −28,245 | $23.36 | −$660K | 2,352,237 |
Loading...
